🟢 LLY.BA is trading 0.9% up today after positive EU regulatory opinion for Jaypirca

LLY.BA is trading at $33660.00 (+0.90%) as sentiment remains constructive following a key regulatory milestone for Jaypirca in the European Union.

• The EMA’s CHMP issued a positive opinion for Jaypirca in chronic lymphocytic leukemia (CLL), with a final European Commission decision expected within one to two months.
• Broader market tone is supportive with major U.S. indices trading higher on June 29.
• Today's price action is modest compared to the significant jump seen on June 26 when the regulatory news was first anticipated.